220 related articles for article (PubMed ID: 25061876)
41. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
[TBL] [Abstract][Full Text] [Related]
42. Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2 downregulation.
Avanzi MP; Goldberg F; Davila J; Langhi D; Chiattone C; Mitchell WB
Br J Haematol; 2014 Mar; 164(6):867-76. PubMed ID: 24383889
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation.
Machlus KR; Wu SK; Stumpo DJ; Soussou TS; Paul DS; Campbell RA; Kalwa H; Michel T; Bergmeier W; Weyrich AS; Blackshear PJ; Hartwig JH; Italiano JE
Blood; 2016 Mar; 127(11):1468-80. PubMed ID: 26744461
[TBL] [Abstract][Full Text] [Related]
44. PKCα negatively regulates in vitro proplatelet formation and in vivo platelet production in mice.
Williams CM; Harper MT; Poole AW
Platelets; 2014; 25(1):62-8. PubMed ID: 23402219
[TBL] [Abstract][Full Text] [Related]
45. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
[TBL] [Abstract][Full Text] [Related]
46. Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome.
Strassel C; Eckly A; Léon C; Petitjean C; Freund M; Cazenave JP; Gachet C; Lanza F
Haematologica; 2009 Jun; 94(6):800-10. PubMed ID: 19377075
[TBL] [Abstract][Full Text] [Related]
47. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
48. The role of proteasome activity for activating and inhibitory signalling in human platelets.
Koessler J; Schuepferling A; Klingler P; Koessler A; Weber K; Boeck M; Kobsar A
Cell Signal; 2019 Oct; 62():109351. PubMed ID: 31260799
[TBL] [Abstract][Full Text] [Related]
49. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis.
Schulze H; Korpal M; Hurov J; Kim SW; Zhang J; Cantley LC; Graf T; Shivdasani RA
Blood; 2006 May; 107(10):3868-75. PubMed ID: 16434494
[TBL] [Abstract][Full Text] [Related]
50. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2.
Tamura S; Suzuki-Inoue K; Tsukiji N; Shirai T; Sasaki T; Osada M; Satoh K; Ozaki Y
Blood; 2016 Mar; 127(13):1701-10. PubMed ID: 26796360
[TBL] [Abstract][Full Text] [Related]
51. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2.
Lecine P; Italiano JE; Kim SW; Villeval JL; Shivdasani RA
Blood; 2000 Aug; 96(4):1366-73. PubMed ID: 10942379
[TBL] [Abstract][Full Text] [Related]
52. A novel method for automated assessment of megakaryocyte differentiation and proplatelet formation.
Salzmann M; Hoesel B; Haase M; Mussbacher M; Schrottmaier WC; Kral-Pointner JB; Finsterbusch M; Mazharian A; Assinger A; Schmid JA
Platelets; 2018 Jun; 29(4):357-364. PubMed ID: 29461915
[TBL] [Abstract][Full Text] [Related]
53. IκB kinase γ/nuclear factor-κB-essential modulator (IKKγ/NEMO) facilitates RhoA GTPase activation, which, in turn, activates Rho-associated KINASE (ROCK) to phosphorylate IKKβ in response to transforming growth factor (TGF)-β1.
Kim HJ; Kim JG; Moon MY; Park SH; Park JB
J Biol Chem; 2014 Jan; 289(3):1429-40. PubMed ID: 24240172
[TBL] [Abstract][Full Text] [Related]
54. The relationship between megakaryocyte ploidy and platelet volume in normal and thrombocytopenic C3H mice.
Corash L; Levin J
Exp Hematol; 1990 Oct; 18(9):985-9. PubMed ID: 2397753
[TBL] [Abstract][Full Text] [Related]
55. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
Kashyap T; Argueta C; Aboukameel A; Unger TJ; Klebanov B; Mohammad RM; Muqbil I; Azmi AS; Drolen C; Senapedis W; Lee M; Kauffman M; Shacham S; Landesman Y
Oncotarget; 2016 Nov; 7(48):78883-78895. PubMed ID: 27713151
[TBL] [Abstract][Full Text] [Related]
56. The proteasome: a novel target for anticancer therapy.
Montagut C; Rovira A; Albanell J
Clin Transl Oncol; 2006 May; 8(5):313-7. PubMed ID: 16760005
[TBL] [Abstract][Full Text] [Related]
57. Proteasome inhibition in the treatment of cancer.
Richardson PG; Mitsiades C; Hideshima T; Anderson KC
Cell Cycle; 2005 Feb; 4(2):290-6. PubMed ID: 15655370
[TBL] [Abstract][Full Text] [Related]
58. FlnA-null megakaryocytes prematurely release large and fragile platelets that circulate poorly.
Jurak Begonja A; Hoffmeister KM; Hartwig JH; Falet H
Blood; 2011 Aug; 118(8):2285-95. PubMed ID: 21652675
[TBL] [Abstract][Full Text] [Related]
59. Regulatory role of proteasome in determination of platelet life span.
Nayak MK; Kulkarni PP; Dash D
J Biol Chem; 2013 Mar; 288(10):6826-34. PubMed ID: 23329846
[TBL] [Abstract][Full Text] [Related]
60. Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4.
Golfier S; Kondo S; Schulze T; Takeuchi T; Vassileva G; Achtman AH; Gräler MH; Abbondanzo SJ; Wiekowski M; Kremmer E; Endo Y; Lira SA; Bacon KB; Lipp M
FASEB J; 2010 Dec; 24(12):4701-10. PubMed ID: 20686109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
